114 related articles for article (PubMed ID: 21421000)
1. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
Seillier A; Giuffrida A
Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
Seillier A; Martinez AA; Giuffrida A
Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
5. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Roohbakhsh A; Keshavarz S; Hasanein P; Rezvani ME; Moghaddam AH
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
[TBL] [Abstract][Full Text] [Related]
7. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
8. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
9. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
11. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Zaitone SA; El-Wakeil AF; Abou-El-Ela SH
Behav Pharmacol; 2012 Aug; 23(4):417-25. PubMed ID: 22750843
[TBL] [Abstract][Full Text] [Related]
13. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
[TBL] [Abstract][Full Text] [Related]
15. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Naderi N; Haghparast A; Saber-Tehrani A; Rezaii N; Alizadeh AM; Khani A; Motamedi F
Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
[TBL] [Abstract][Full Text] [Related]
16. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
Haller J; Barna I; Barsvari B; Gyimesi Pelczer K; Yasar S; Panlilio LV; Goldberg S
Psychopharmacology (Berl); 2009 Jul; 204(4):607-16. PubMed ID: 19259645
[TBL] [Abstract][Full Text] [Related]
17. Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597.
Matricon J; Seillier A; Giuffrida A
Neurosci Res; 2016 Sep; 110():49-58. PubMed ID: 27091613
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.
Carnevali L; Vacondio F; Rossi S; Macchi E; Spadoni G; Bedini A; Neumann ID; Rivara S; Mor M; Sgoifo A
Sci Rep; 2015 Dec; 5():18218. PubMed ID: 26656183
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid modulation of male rat sexual behavior.
Gorzalka BB; Morrish AC; Hill MN
Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389
[TBL] [Abstract][Full Text] [Related]
20. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
